GBT
DXCM icon

Grove Bank & Trust’s DexCom DXCM Stock Holding History

Grove Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.78K Hold
67
– – ﹤0.01% 721
2026
Q2 		$4.51K Hold
67
– – ﹤0.01% 740
2026
Q1 		$4.21K Buy
67
+8
+14% +$557 ﹤0.01% 727
2025
Q4 		$3.92K Hold
59
– – ﹤0.01% 757
2025
Q3 		$3.97K Sell
59
-15
-20% -$1.19K ﹤0.01% 736
2025
Q2 		$6.46K Sell
74
-1
-1% -$78 ﹤0.01% 664
2025
Q1 		$5.12K Sell
75
-69
-48% -$5.63K ﹤0.01% 665
2024
Q4 		$11.2K Buy
144
+88
+157% +$6.51K ﹤0.01% 519
2024
Q3 		$3.75K Hold
56
– – ﹤0.01% 584
2024
Q2 		$6.35K Hold
56
– – ﹤0.01% 510
2024
Q1 		$7.77K Sell
56
-49
-47% -$6.16K ﹤0.01% 512
2023
Q4 		$13K Hold
105
– – ﹤0.01% 466
2023
Q3 		$9.8K Buy
105
+49
+88% +$5.52K ﹤0.01% 522
2023
Q2 		$7.2K Sell
56
-22
-28% -$2.66K ﹤0.01% 527
2023
Q1 		$9.06K Buy
78
+68
+680% +$7.61K ﹤0.01% 520
2022
Q4 		$1K Buy
+10
New +$1.1K ﹤0.01% 601

Other funds holding DXCM

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
HH
HWG Holdings Houston, Texas $434M AUM 42.17% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return
AIC
Argus Investors Counsel New York $129M AUM 31.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
HAG
HF Advisory Group Annapolis, Maryland $336M AUM 14.9% 1-Year Est. Return

Grove Bank & Trust's DXCM Position: Q3 2026 in Review

Grove Bank & Trust held its DexCom (DXCM) position steady in Q3 2026 at 67 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Grove Bank & Trust first reported a position in DXCM in Q4 2022 and has held it in 16 quarters since. The position peaked at $13K in Q4 2023. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Grove Bank & Trust held 67 shares of DexCom worth $5.78K as of Q3 2026.
  • Grove Bank & Trust left its DexCom share count unchanged in Q3 2026.
  • DexCom made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #721 holding.
  • Grove Bank & Trust first reported a position in DexCom in Q4 2022 and has held it in 16 quarters since.
  • Grove Bank & Trust's DexCom position peaked at $13K in Q4 2023.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.